APA (7th ed.) Citation

P, S., F, C., YK, B., V, J., X, L., N, D., . . . G, R. (2025). A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease. Molecular therapy. Methods & clinical development, 33(2), 101464. https://doi.org/10.1016/j.omtm.2025.101464

Chicago Style (17th ed.) Citation

P, Sellier, et al. "A Myotropic AAV Vector Combined with Skeletal Muscle Cis-regulatory Elements Improve Glycogen Clearance in Mouse Models of Pompe Disease." Molecular Therapy. Methods & Clinical Development 33, no. 2 (2025): 101464. https://doi.org/10.1016/j.omtm.2025.101464.

MLA (9th ed.) Citation

P, Sellier, et al. "A Myotropic AAV Vector Combined with Skeletal Muscle Cis-regulatory Elements Improve Glycogen Clearance in Mouse Models of Pompe Disease." Molecular Therapy. Methods & Clinical Development, vol. 33, no. 2, 2025, p. 101464, https://doi.org/10.1016/j.omtm.2025.101464.